Page 19 - Alex Sinclair News Today

The type 2 diabetes therapy is being tested on patients in a phase 2 clinical trial - News - PharmaTimes

The researchers reveal that this is a major trial for the rare and debilitating condition IIH that can lead to people going blind and suffering disabling daily headaches.

A new experiment has discovered that patients suffering from blinding headaches known as Idiopathic Intercranial Hypertension (IIH) might be treated with an injectable peptide used to treat type 2 diabetes.

Get latest articles and stories on Health at LatestLY. A new experiment has discovered that patients suffering from blinding headaches known as Idiopathic Intercranial Hypertension (IIH) might be treated with an injectable peptide used to treat type 2 diabetes. Health News | New Medicine to Lower Brain Pressure Might Treat Blinding IIH Headaches: Study.

A study for idiopathic intercranial hypertension is the first to show rapid and a major reduction in brain pressure and monthly headaches.

Patients with 'blinding' headaches known as Idiopathic Intercranial Hypertension could be treated with an injectable peptide used for type 2 diabetes, a new trial has found.

The classic SIM card-based standard is slowly being replaced by newer eSIM tech, but mobile manufacturers and SoC designers are already working to go beyond that. Qualcomm's...

The Flash kids must save the day as the One-Minute War continues in this preview of Flash #794, in stores Tuesday from DC Comics.

From the blog of Alan Silverstein at The Times of Israel

The objective of the collaboration is to create a scalable framework for establishing commercial roaming agreements.